These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31135652)

  • 1. What Role Should Cytology Play in Cervical Cancer Screening?
    Perkins RB; Austin RM; Zhao C; Saslow D; Massad LS
    J Low Genit Tract Dis; 2019 Jul; 23(3):205-209. PubMed ID: 31135652
    [No Abstract]   [Full Text] [Related]  

  • 2. Should We Always Look Before We LEEP? A Discussion of the Pros and Cons of Colposcopic Biopsy Prior to Treatment.
    Guido R; Perkins RB; Smith KM
    J Low Genit Tract Dis; 2019 Apr; 23(2):147-150. PubMed ID: 30817690
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
    Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
    Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective.
    Lorenzi AT; Syrjänen KJ; Longatto-Filho A
    Virol J; 2015 Jul; 12():112. PubMed ID: 26208521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-based cytology for cervical screening.
    Payne N; Chilcott J; McGoogan E
    Cytopathology; 2000 Dec; 11(6):469-70. PubMed ID: 11194077
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HPV test in the prevention of cervix cancer].
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen E
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):396-7. PubMed ID: 22353829
    [No Abstract]   [Full Text] [Related]  

  • 8. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
    Moseley R
    Cytopathology; 2002 Apr; 13(2):135-6. PubMed ID: 11952756
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years.
    Jin XW; Lipold L; Foucher J; Sikon A; Brainard J; Belinson J; Schramm S; Nottingham K; Hu B; Rothberg MB
    J Gen Intern Med; 2016 Nov; 31(11):1338-1344. PubMed ID: 27418345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising future cervical screening strategies.
    Kitchener H
    Papillomavirus Res; 2019 Jun; 7():201-203. PubMed ID: 30978414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
    Xu L; Oštrbenk A; Poljak M; Arbyn M
    J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hovering on the threshold of change.
    Andrews J
    J Low Genit Tract Dis; 2015 Apr; 19(2):89-90. PubMed ID: 25574660
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Authors' reply.
    Herbert A; Johnson J
    Cytopathology; 2002 Apr; 13(2):133. PubMed ID: 11952753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma].
    Sun XF; Gu YQ; Wang AC; Wang J; Xie JL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Gynecological Cytology in the Era of Molecular Testing.
    Longatto-Filho A
    Acta Cytol; 2016; 60(6):499-500. PubMed ID: 27829246
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
    J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-Based Screening for Cervical Cancer Using Visual Inspection With Acetic Acid: Results and Lessons Learned From a Pilot Study in Vietnam.
    Vu LTH; Tran HTD; Nguyen BT; Bui HTT; Nguyen AD; Pham NB
    J Public Health Manag Pract; 2018; 24 Suppl 2():S3-S8. PubMed ID: 29369251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Sasieni P
    J Med Screen; 2010; 17(1):2-3. PubMed ID: 20356937
    [No Abstract]   [Full Text] [Related]  

  • 19. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Rebolj M; Lynge E
    J Med Screen; 2010; 17(1):1-2. PubMed ID: 20356936
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening.
    Ting J; Smith JS; Myers ER
    J Low Genit Tract Dis; 2015 Oct; 19(4):333-9. PubMed ID: 26225945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.